Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

DeSantis seeks grand jury investigation of COVID-19 vaccines

Florida Gov. Ron DeSantis is asking the state’s Supreme Court to convene a grand jury to investigate “any and all wrongdoing” with respect to the COVID-19 vaccines

The Independent UK

IBD 50 Stocks To Watch: Biotech Leader Catalyst Pharmaceuticals Near New High

Biotech leader Catalyst Pharmaceuticals is one of the top stocks to watch, after rising past its latest buy point.

Investors Business Daily

Sickle cell cure will be cost-effective if health disparities considered -study finds

(This Dec.13 story has been corrected to remove reference to Sanofi in the fifth paragraph)

Reuters

From analysis to the latest developments in health,
read the most diverse news in one place.

UK pharmacists report sharp rise in prices for strep A antibiotics

Concerns raised over pharmacists’ losses as market prices outpace NHS reimbursement tariffs

The Guardian - UK

Northern Ireland antibiotics supply facing "exceptional" demand, Department says

Department says "system has been working hard to replenish stocks as quickly as possible"

Belfast Live

Researchers from Moderna and Merck just made a breakthrough with a skin cancer vaccine

Thank you, science.

Mic

1 Stock That Could Easily Beat the Market Over the Next 5 Years

Pfizer (PFE) benefited substantially from the COVID-19 pandemic. It pays a more than 3% dividend, making it attractive for investors looking for stable income. The stock has picked up steady momentum, and its robust fundamentals should help the company easily outpace the market in the coming years. Let’s discuss this…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

GILD Stock: Is It Still a Smart Investment Ahead of 2023?

GILD gained prominence during the pandemic, but the company’s COVID-19 drug Veklury registered a decline in sales because of declining COVID-19 cases. However, it beat revenue and earnings estimates in the previous quarter. Will the company be able to record further growth in the coming year? Read more to learn…

StockNews.com

Merck, Moderna detail potential skin cancer vaccine progress

Shares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study

The Independent UK

Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up

Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results sent Moderna shares soaring.

Investors Business Daily

China Allows Online Sales of Pfizer Covid Pill Paxlovid

Patients can buy the antiviral drug after presenting a positive test result

Caixin Global

MSPs ask for update on Crown Office plans to bypass UK drug laws

MSPs have called for an update on the progress of plans to create safe drug consumption rooms in Scotland.

The National (Scotland)

Strep A outbreak: Everything we know as 19 children die of bacterial infection

Parents advised to be mindful of signs including characteristic rash and red tongue also known as ‘strawberry tongue’

The Independent UK

Strep A cases in your area as UK infections rise 30 per cent

Infections have been found around the country, as authorities warn parents to be vigilant

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

The debate over synthetic 'shrooms

You can't patent naturally-occurring molecules like psilocybin. That's led to a rush to find a synthetic blend

WEKU

A major drugmaker plans to sell overdose-reversal nasal spray Narcan over the counter

Emergent BioSolutions has applied to the Food and Drug Administration to sell the opioid overdose-reversal drug over the counter. Addiction experts say it may be a key step to lower fentanyl deaths.

Evening Standard

Strep A: London parents describe ‘nightmare’ trying to get antibiotics

Parents with sick children told the Standard that dozens of pharmacists they visited were completely out of stock

Birmingham Post

Shield Therapeutics secures £15.1m in raise and seals deal with healthcare company

The iron deficiency drug specialist will use the proceeds to mount a campaign on the US market

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Editorial: Mask, needle, health: Masks and vaccines are still our best shot to withstand a winter surge in respiratory infections

The clunky word “tripledemic” is now on many lips. It means we now face a winter with three different respiratory viruses with similar symptoms are spreading rapidly, and stressing hospital capacity.

Reuters

Indonesia to produce Merck's HPV vaccines to combat cervical cancer

Indonesia will produce drugmaker Merck Co's vaccines for human papillomavirus (HPV), the chief of its state-owned pharmaceutical company Bio Farma said on Tuesday, in a bid to combat HPV-linked cervical cancer in the country.

Reuters

Japan's Meiji Holdings says drug unit started late-stage trial for COVID vaccine

Japan's Meiji Holdings Co said on Tuesday its drug subsidiary had started a Phase III trial of an mRNA-based vaccine for COVID-19.

Reuters

Shionogi says Japan government to buy 1 million more COVID pill doses

Shionogi Co Ltd said on Tuesday the Japanese government agreed to purchase an additional 1 million doses of its oral treatment for COVID-19.

AAP

CSL names McKenzie as new CEO

COO Paul McKenzie will take over as CSL chief executive next year when Paul Perreault retires following a decade leading the blood products giant.

Investors Business Daily

Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues

The Food and Drug Administration approved Mirati's rival to Amgen's lung cancer drug, sending MRTX stock higher on Tuesday.

Reuters

U.S. FDA approves Mirati's lung cancer drug

The U.S. Food and Drug Administration approved Mirati Therapeutics Inc's lung cancer drug adagrasib, the company said on Monday, sending its shares up more than 8% in extended trading.

1 … 65 66 67 68

People

Ron DeSantis

7,461 stories

Dipanjan BanchurSince

722 stories

Christian Schmollinger

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UK Health Security Agency

481 stories

IBD MarketSmith

447 stories

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.